Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer
Introduction - Sentinel lymph node biopsy in breast infiltrating cancer is indicatedfor lesions not exceeding 50 mm (T1-T2) and controversial in the presence of axillary adenopathy and after neo adjuvant chemotherapy. Sentinel lymph node biopsy is assessed by an identification rate greater than 90%...
| Published in: | Journal de la Faculté de Médecine d'Oran |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
University of Oran 1
2017-06-01
|
| Subjects: | |
| Online Access: | https://confajol3.ajol.info/index.php/jmfo/article/view/461 |